Lonza Inc. goes viral into Houston’s medical market

​PEARLAND – Lonza Houston Inc., an international viral and cell therapy manufacturer, will construct a new biotech facility on an 11-acre site in a growing area of Pearland.

Lonza will join a number of medical field companies — such as Merit Medical Systems and Pearland Surgery Center — to locate to the city’s Lower Kirby Urban District near the intersection of Beltway 8 and Hwy. 288.

The new center will house viral and immunotherapy development and manufacturing for products that range from active pharmaceutical ingredients to drinking water sanitizers. 

Lonza expects to complete construction of the facility by third quarter 2017. About 50 employees will work at the new center at its launch, and Lonza plans to include additional personnel in the future.